Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2.
Clin Cancer Res
; 25(4): 1434, 2019 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-30770493
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article